Immunomodulation and T Helper TH1/TH2 Response Polarization by CeO2 and TiO2 Nanoparticles

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Schanen, Brian C ^a,b   Das, Soumen ^c   Reilly, Christopher M ^d   Warren, William L ^a,b   Self, William T ^b   Seal, Sudipta ^c   Drake III, Donald R ^a  

^a SANOFI PASTEUR   (France)

^b UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^c University of Central Florida   (United States)

^d EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CERIUM OXIDE; INFLAMMASOME; INTERLEUKIN 10; INTERLEUKIN 1BETA; NANOPARTICLE; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE; TITANIUM DIOXIDE;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ARTICLE; CATALYSIS; CELL FUNCTION; CELL MATURATION; CELLULAR IMMUNITY; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; TH1 CELL; TH2 CELL;

ANALYSIS OF VARIANCE; CATALYSIS; CELL PROLIFERATION; CERIUM; DENDRITIC CELLS; FLOW CYTOMETRY; FLUORESCENCE; HUMANS; IMMUNOMODULATION; INFLAMMASOMES; METAL NANOPARTICLES; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; T-LYMPHOCYTES, HELPER-INDUCER; TITANIUM;

EID: 84877255309     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062816     Document Type: Article

References (63)

1. Patil S, Sandberg A, Heckert E, Self W, Seal S, (2007) Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. Biomaterials 28: 4600-4607.
2. Colon J, Hsieh N, Ferguson A, Kupelian P, Seal S, et al. (2010) Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomedicine 6: 698-705.
3. Hirst SM, Karakoti AS, Tyler RD, Sriranganathan N, Seal S, et al. (2009) Anti-inflammatory properties of cerium oxide nanoparticles. Small 5: 2848-2856.
4. Fan AM, Alexeeff G, (2010) Nanotechnology and nanomaterials: toxicology, risk assessment, and regulations. J Nanosci Nanotechnol 10: 8646-8657.
5. McNeil SE, (2005) Nanotechnology for the biologist. J Leukoc Biol 78: 585-594.
6. Hanley C, Thurber A, Hanna C, Punnoose A, Zhang J, et al. (2009) The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction. Nanoscale Res Lett 4: 1409-1420.
7. Mayer A, Vadon M, Rinner B, Novak A, Wintersteiger R, et al. (2009) The role of nanoparticle size in hemocompatibility. Toxicology 258: 139-147.
8. Schanen BC, Karakoti AS, Seal S, Drake DR, 3rd, Warren WL, et al (2009) Exposure to titanium dioxide nanomaterials provokes inflammation of an in vitro human immune construct. ACS Nano 3: 2523-2532.
9. Deng ZJ, Liang M, Monteiro M, Toth I, Minchin RF, (2011) Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat Nanotechnol 6: 39-44.
10. Duffin R, Tran L, Brown D, Stone V, Donaldson K, (2007) Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal Toxicol 19: 849-856.
11. Shin SH, Ye MK, Kim HS, Kang HS, (2007) The effects of nano-silver on the proliferation and cytokine expression by peripheral blood mononuclear cells. Int Immunopharmacol 7: 1813-1818.
12. Sun Q, Tan D, Zhou Q, Liu X, Cheng Z, et al. (2012) Oxidative damage of lung and its protective mechanism in mice caused by long-term exposure to titanium dioxide nanoparticles. J Biomed Mater Res A.
13. Thevenot P, Cho J, Wavhal D, Timmons RB, Tang L, (2008) Surface chemistry influences cancer killing effect of TiO2 nanoparticles. Nanomedicine 4: 226-236.
14. Thevenot P, Hu W, Tang L, (2008) Surface chemistry influences implant biocompatibility. Curr Top Med Chem 8: 270-280.
15. Finkel T, (2000) Redox-dependent signal transduction. FEBS Lett 476: 52-54.
16. Gaucher D, Therrien R, Kettaf N, Angermann BR, Boucher G, et al. (2008) Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 205: 3119-3131.
17. Byers AM, Tapia TM, Sassano ER, Wittman V, (2009) In vitro antibody response to tetanus in the MIMIC system is a representative measure of vaccine immunogenicity. Biologicals 37: 148-151.
18. Higbee RG, Byers AM, Dhir V, Drake D, Fahlenkamp HG, et al. (2009) An immunologic model for rapid vaccine assessment - a clinical trial in a test tube. Altern Lab Anim 37Suppl 1: 19-27.
19. Song H, Wittman V, Byers A, Tapia T, Zhou B, et al. (2010) In vitro stimulation of human influenza-specific CD8+ T cells by dendritic cells pulsed with an influenza virus-like particle (VLP) vaccine. Vaccine 28: 5524-5532.
20. Wittman V, Byers A, Drake D, Kachurina O, Tapia T, et al. (2010) New tests for an old foe: an update on influenza screening. IDrugs 13: 248-253.
21. Dhir V, Fort M, Mahmood A, Higbee R, Warren W, et al. (2012) A predictive biomimetic model of cytokine release induced by TGN1412 and other therapeutic monoclonal antibodies. J Immunotoxicol 9: 34-42.
22. Ma Y, Poisson L, Sanchez-Schmitz G, Pawar S, Qu C, et al. (2010) Assessing the immunopotency of Toll-like receptor agonists in an in vitro tissue-engineered immunological model. Immunology 130: 374-387.
23. Schanen BC, De Groot AS, Moise L, Ardito M, McClaine E, et al. (2011) Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4(+) T cells against the swine-origin H1N1 influenza virus. Vaccine 29: 3299-3309.
24. Schanen BC, Drake DR, 3rd (2008) A novel approach for the generation of human dendritic cells from blood monocytes in the absence of exogenous factors. J Immunol Methods 335: 53-64.
25. Moser JM, Sassano ER, Leistritz del C, Eatrides JM, Phogat S, et al. (2010) Optimization of a dendritic cell-based assay for the in vitro priming of naive human CD4+ T cells. J Immunol Methods 353: 8-19.
26. Dhir V, Fort M, Mahmood A, Higbee R, Warren W, et al. (2011) A predictive biomimetic model of cytokine release induced by TGN1412 and other therapeutic monoclonal antibodies. J Immunotoxicol.
27. Dowding JM, Dosani T, Kumar A, Seal S, Self WT, (2012) Cerium oxide nanoparticles scavenge nitric oxide radical (NO). Chem Commun (Camb) 48: 4896-4898.
28. Wason MS, Colon J, Das S, Seal S, Turkson J, et al. (2012) Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production. Nanomedicine.
29. Xu M, Huang N, Xiao Z, Lu Z, (1998) Photoexcited TiO2 nanoparticles through •OH-radicals induced malignant cells to necrosis. Supramolecular Science 5: 449-451.
30. Zhang AP, Sun YP, (2004) Photocatalytic killing effect of TiO2 nanoparticles on Ls-174-t human colon carcinoma cells. World J Gastroenterol 10: 3191-3193.
31. Bar-Ilan O, Louis KM, Yang SP, Pedersen JA, Hamers RJ,et al. Titanium dioxide nanoparticles produce phototoxicity in the developing zebrafish. Nanotoxicology 0: 1-10.
32. Yang D, Zhao Y, Guo H, Li Y, Tewary P, et al. (2010) [Gd@C(82)(OH)(22)](n) nanoparticles induce dendritic cell maturation and activate Th1 immune responses. ACS Nano 4: 1178-1186.
33. Rutault K, Alderman C, Chain BM, Katz DR, (1999) Reactive oxygen species activate human peripheral blood dendritic cells. Free Radic Biol Med 26: 232-238.
34. Bruchhausen S, Zahn S, Valk E, Knop J, Becker D, (2003) Thiol antioxidants block the activation of antigen-presenting cells by contact sensitizers. J Invest Dermatol 121: 1039-1044.
35. Kotake Y, Moore DR, Vasquez-Walden A, Tabatabaie T, Sang H, (2003) Antioxidant amplifies antibiotic protection in the cecal ligation and puncture model of microbial sepsis through interleukin-10 production. Shock 19: 252-256.
36. Chauveau C, Remy S, Royer PJ, Hill M, Tanguy-Royer S, et al. (2005) Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood 106: 1694-1702.
37. Warheit DB, Reed KL, Sayes CM, (2009) A role for nanoparticle surface reactivity in facilitating pulmonary toxicity and development of a base set of hazard assays as a component of nanoparticle risk management. Inhal Toxicol 21Suppl 1: 61-67.
38. Zhu ZJ, Ghosh PS, Miranda OR, Vachet RW, Rotello VM, (2008) Multiplexed screening of cellular uptake of gold nanoparticles using laser desorption/ionization mass spectrometry. J Am Chem Soc 130: 14139-14143.
39. Allouni ZE, Hol PJ, Cauqui MA, Gjerdet NR, Cimpan MR, (2012) Role of physicochemical characteristics in the uptake of TiO2 nanoparticles by fibroblasts. Toxicol In Vitro 26: 469-479.
40. Churg A, Stevens B, Wright JL, (1998) Comparison of the uptake of fine and ultrafine TiO2 in a tracheal explant system. Am J Physiol 274: L81-86.
41. Stringer B, Kobzik L, (1996) Alveolar macrophage uptake of the environmental particulate titanium dioxide: role of surfactant components. Am J Respir Cell Mol Biol 14: 155-160.
42. Asati A, Santra S, Kaittanis C, Perez JM, (2010) Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles. ACS Nano 4: 5321-5331.
43. Gaiser BK, Fernandes TF, Jepson MA, Lead JR, Tyler CR, et al. (2012) Interspecies comparisons on the uptake and toxicity of silver and cerium dioxide nanoparticles. Environ Toxicol Chem 31: 144-154.
44. Yazdi AS, Guarda G, Riteau N, Drexler SK, Tardivel A, et al. (2010) Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1alpha and IL-1beta. Proc Natl Acad Sci U S A 107: 19449-19454.
45. Paulsen M, Valentin S, Mathew B, Adam-Klages S, Bertsch U, et al. (2011) Modulation of CD4+ T-cell activation by CD95 co-stimulation. Cell Death Differ 18: 619-631.
46. Goncalves DM, Chiasson S, Girard D, (2010) Activation of human neutrophils by titanium dioxide (TiO2) nanoparticles. Toxicol In Vitro 24: 1002-1008.
47. Donaldson K, Beswick PH, Gilmour PS, (1996) Free radical activity associated with the surface of particles: a unifying factor in determining biological activity? Toxicol Lett 88: 293-298.
48. Liu Y, Jiao F, Qiu Y, Li W, Lao F, et al. (2009) The effect of Gd@C82(OH)22 nanoparticles on the release of Th1/Th2 cytokines and induction of TNF-alpha mediated cellular immunity. Biomaterials. 30: 3934-3945.
49. Lutsiak ME, Kwon GS, Samuel J, (2006) Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses. J Pharm Pharmacol 58: 739-747.
50. Lander HM, Milbank AJ, Tauras JM, Hajjar DP, Hempstead BL, et al. (1996) Redox regulation of cell signalling. Nature 381: 380-381.
51. Tang H, Cao W, Kasturi SP, Ravindran R, Nakaya HI, et al. (2010) The T helper type 2 response to cysteine proteases requires dendritic cell-basophil cooperation via ROS-mediated signaling. Nat Immunol 11: 608-617.
52. Fialkow L, Wang Y, Downey GP, (2007) Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic Biol Med 42: 153-164.
53. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A, (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19: 683-765.
54. Laouini D, Alenius H, Bryce P, Oettgen H, Tsitsikov E, et al. (2003) IL-10 is critical for Th2 responses in a murine model of allergic dermatitis. J Clin Invest 112: 1058-1066.
55. Boonstra A, Rajsbaum R, Holman M, Marques R, Asselin-Paturel C, et al. (2006) Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. J Immunol 177: 7551-7558.
56. Tse HM, Milton MJ, Piganelli JD, (2004) Mechanistic analysis of the immunomodulatory effects of a catalytic antioxidant on antigen-presenting cells: implication for their use in targeting oxidation-reduction reactions in innate immunity. Free Radic Biol Med 36: 233-247.
57. Schroecksnadel K, Fischer B, Schennach H, Weiss G, Fuchs D, (2007) Antioxidants suppress Th1-type immune response in vitro. Drug Metab Lett 1: 166-171.
58. Boscolo P, Bellante V, Leopold K, Maier M, Di Giampaolo L, et al. (2010) Effects of palladium nanoparticles on the cytokine release from peripheral blood mononuclear cells of non-atopic women. J Biol Regul Homeost Agents 24: 207-214.
59. Cai X, Sezate SA, Seal S, McGinnis JF, (2012) Sustained protection against photoreceptor degeneration in tubby mice by intravitreal injection of nanoceria. Biomaterials 33: 8771-8781.
60. Donald R Drake III, Inderpal Singh, Michael N Nguyen, Anatoly Kachurin, Vaughan Wittman, et al. (2012) In Vitro Biomimetic Model of the Human Immune System for Predictive Vaccine Assessments. Disruptive Science and Technology 1: 28-40.
61. Yang HY, Zhu SK, Pan N, (2003) Studying the Mechanisms of Titanium Dioxide as Ultraviolet-Blocking Additive for Films and Fabrics by an Improved Scheme. Journal of Applied Polymer Science 92: 3201-3210.
62. Lamkanfi M, Malireddi RK, Kanneganti TD, (2009) Fungal zymosan and mannan activate the cryopyrin inflammasome. J Biol Chem 284: 20574-20581.
63. Karakoti AS, Singh S, Kumar A, Malinska M, Kuchibhatla SV, et al. (2009) PEGylated nanoceria as radical scavenger with tunable redox chemistry. J Am Chem Soc 131: 14144-14145.